Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Beuers

Showing results (241-250 of 298) with videos related to

Pageof 30
Sort By:
Gastroenterology|October 8, 2020
Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled TrialElsemieke de Vries, Ruth Bolier, Jorn Goet, et al.
Human Gene Therapy|September 11, 2019
Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar SyndromeSem J Aronson, Philippe Veron, Fanny Collaud, et al.
Hepatology (Baltimore, Md.)|March 26, 2016
Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignanciesMarieke E Doorenspleet, Lowiek M Hubers, Emma L Culver, et al.
Scientific Reports|August 19, 2016
Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transportDaniël A Lionarons, Michal Heger, Rowan F van Golen, et al.
Clinical Reviews in Allergy & Immunology|June 25, 2014
IgG4-associated cholangitis: a comprehensive reviewLowiek M Hubers, Lucas J Maillette de Buy Wenniger, Marieke E Doorenspleet, et al.
The New England Journal of Medicine|August 16, 2023
Gene Therapy in Patients with the Crigler-Najjar SyndromeLorenzo D'Antiga, Ulrich Beuers, Giuseppe Ronzitti, et al.
Obesity Research & Clinical Practice|December 28, 2025
Children's experience of screening and evaluation for MASLD in overweight and obesityAnne-Sophie R Stroes, Laura Draijer, Hedy A van Oers, et al.
Gastroenterology|June 16, 2010
Lysophosphatidic acid is a potential mediator of cholestatic pruritusAndreas E Kremer, Job J W W Martens, Wim Kulik, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2022
Disease burden in primary sclerosing cholangitis in the Netherlands: A long-term follow-up studyKim N van Munster, Bregje Mol, Jorn C Goet, et al.
Hepatology (Baltimore, Md.)|April 5, 2012
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventionsAndreas E Kremer, Remco van Dijk, Pamela Leckie, et al.
Pageof 30

Showing results (241-250 of 298) with videos related to

Sort By:
Pageof 30
Gastroenterology|October 8, 2020
Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled TrialElsemieke de Vries, Ruth Bolier, Jorn Goet, et al.
Human Gene Therapy|September 11, 2019
Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar SyndromeSem J Aronson, Philippe Veron, Fanny Collaud, et al.
Hepatology (Baltimore, Md.)|March 26, 2016
Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignanciesMarieke E Doorenspleet, Lowiek M Hubers, Emma L Culver, et al.
Scientific Reports|August 19, 2016
Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transportDaniël A Lionarons, Michal Heger, Rowan F van Golen, et al.
Clinical Reviews in Allergy & Immunology|June 25, 2014
IgG4-associated cholangitis: a comprehensive reviewLowiek M Hubers, Lucas J Maillette de Buy Wenniger, Marieke E Doorenspleet, et al.
The New England Journal of Medicine|August 16, 2023
Gene Therapy in Patients with the Crigler-Najjar SyndromeLorenzo D'Antiga, Ulrich Beuers, Giuseppe Ronzitti, et al.
Obesity Research & Clinical Practice|December 28, 2025
Children's experience of screening and evaluation for MASLD in overweight and obesityAnne-Sophie R Stroes, Laura Draijer, Hedy A van Oers, et al.
Gastroenterology|June 16, 2010
Lysophosphatidic acid is a potential mediator of cholestatic pruritusAndreas E Kremer, Job J W W Martens, Wim Kulik, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2022
Disease burden in primary sclerosing cholangitis in the Netherlands: A long-term follow-up studyKim N van Munster, Bregje Mol, Jorn C Goet, et al.
Hepatology (Baltimore, Md.)|April 5, 2012
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventionsAndreas E Kremer, Remco van Dijk, Pamela Leckie, et al.
Pageof 30